Patients may want to revert back to previously used methods as pandemic restrictions ease.

Consider the impact of new digital solutions on clinical sites, including training and patient support needs.

When designing trial plans, consider the potential for demographic bias towards technology proficiency.

Prioritize being flexible and smart, selecting multiple technologies that enable ongoing innovation while following agile practices for integrating new vendors into core business processes.

Change the way that data, analytics and ecosystem partnerships are used across the entire drug development process, leading to improved clinical and patient outcomes, accelerated clinical trial timelines, and reduced costs.

Reimagine clinical development by leveraging machine learning and real-world data to power patient-centric design, formulate trial strategy and employ risk-based everywhere approaches.